CytoSorbents appoints Kathleen P. Bloch as full-time CFO with new employment agreement

Cytosorbents Corp

Bloch returns as CFO effective Sept 2, 2023, replacing former CFO D'Amico after his departure following an investigation.
Annual base salary of $425,000; eligible for cash bonus up to 45% of base salary at CEO's discretion.
Equity award: 45,000 RSUs (25k vest immediately, 10k on each of first two anniversaries) and 30,000 options (same vesting schedule).
Employment agreement runs through Dec 31, 2025 unless terminated earlier.

item 1.01 item 5.02 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Kathleen P. Bloch

Chief Financial Officer

CTSO · Cytosorbents Corp

Effective: 2023-09-02
Filed: September 19, 2023, 7:59 PM ET

Ms. Bloch will continue to serve as the Company’s Chief Financial Officer.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Kathleen P. Bloch was appointed as Chief Financial Officer at Cytosorbents Corp.

Action: appointed
Role: Chief Financial Officer

Exact text from the filing

Ms. Bloch will continue to serve as the Company’s Chief Financial Officer.

View on SEC.gov

Cytosorbents Corp filing history →

Source: SEC EDGAR

accession 0001104659-23-101952

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.